comparemela.com

Latest Breaking News On - Trelegy ellipta - Page 10 : comparemela.com

1 Healthcare Stock That Could Fly Higher After a Strong Q4

Respiratory diseases advocate living with severe asthma

Respiratory diseases advocate living with severe asthma
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

GlaxoSmithKline (NYSE:GSK) Rating Lowered to Hold at Zacks Investment Research

GlaxoSmithKline (NYSE:GSK) Rating Lowered to Hold at Zacks Investment Research
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Japan sees drug lag as foreign pharmas pass up the market amid pricing pressure, industry group warns

Japan has been leveraging different policy tools to rein in drug expenditures, and that is scaring foreign pharmas away. The country is seeing “trends of a drug lag” as approvals decrease, Yasushi Okada, president of the Japan Pharmaceutical Manufacturers Association and Eisai’s chief operating officer, said.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.